NAV
$38.51
AUM
$248.5M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.98
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +8.93% | +2.15% | +6.93% | +16.84% | +15.30% | +8.30% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 4.53% |
| 2 | ROP.SW | Roche Holding AG Ordinary Shares new | 2.05% |
| 3 | NOVN.SW | Novartis AG Registered Shares | 2.00% |
| 4 | AZN.L | AstraZeneca PLC | 1.99% |
| 5 | NESN.SW | Nestle SA | 1.82% |
| 6 | SIE.DE | Siemens AG | 1.69% |
| 7 | CBA.AX | Commonwealth Bank of Australia | 1.41% |
| 8 | 7203.T | Toyota Motor Corp | 1.39% |
| 9 | SAP.DE | SAP SE | 1.28% |
| 10 | SU.PA | Schneider Electric SE | 1.23% |
The Advisor employs a "passive management"?-?or indexing?-?investment approach designed to track the performance of the underlying index. The underlying index is designed to deliver exposure to equity securities of companies meeting environmental, social and corporate governance (ESG) criteria developed by Candriam and weighted using a market-capitalization weighting methodology.
Inception Date: 2019-12-17